# Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer

> **NCT00019084** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Lung Cancer
- Ovarian Cancer
- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** mutant p53 peptide pulsed dendritic cell vaccine
- **BIOLOGICAL:** ras peptide cancer vaccine
- **BIOLOGICAL:** sargramostim
- **BIOLOGICAL:** therapeutic autologous lymphocytes
- **BIOLOGICAL:** therapeutic tumor infiltrating lymphocytes

## Key facts

- **NCT ID:** NCT00019084
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-02
- **Primary completion:** —
- **Final completion:** 2003-05
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00019084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00019084, "Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00019084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*